# Geriatric Psychiatry Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elizabeth I (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE003-SYN
- Date: 2026-01-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gideon Rasmussen-Hale, MD
- Calendar frame: modern shifted

- Requested by: Philippa Ashcombe-Nwosu, MD

## Reason for consultation

Low mood, poor sleep, poor appetite, and 6 percent weight loss over three months in a 69-year-old woman after several bereavements, with PHQ-9 17, GDS-15 10, and a passive death wish. Please confirm the diagnosis and advise on treatment suited to an older adult and on her safety. **S**

## History

Ms. Tudor is seen at the request of Dr. Ashcombe-Nwosu, two weeks after her first visit, at the end of the clinic day at her request. She describes three months of a heavy, unremitting low mood that does not lift with good news, loss of pleasure in music, riding, and company, waking at 2 or 3 in the morning, poor appetite with weight loss, slowed thinking, and a sense that she has outlived her circle. She dwells on a former protégé and confidant who died two years ago after a bitter breach, and on her own part in it, with guilt that comes in waves. She has had no period of elevated or irritable mood, reduced need for sleep, or racing thoughts, and no hallucinations or fixed false beliefs. The passive wish not to wake has not recurred since the first visit; she has never harmed herself. She has no memory complaints and continues to manage her papers. She stopped diphenhydramine two weeks ago and sleeps about four hours. She drinks a small glass of wine some evenings. She prefers to be treated privately and individually and is willing to take a medicine if it is explained to her. **S**

## Examination

| System | Finding |
|---|---|
| Appearance and behavior | Thin, carefully dressed, upright; formal at first, then open; frequent sighs |
| Speech | Slow and quiet; coherent |
| Mood and affect | Mood "heavy"; affect constricted, tearful when she speaks of the friend she lost |
| Thought process and content | Linear; guilt about the breach with her friend but no delusional guilt, poverty, or illness beliefs; no suicidal ideation today |
| Perception | No hallucinations |
| Cognition | Alert and oriented; attention and recall intact in conversation, consistent with the MoCA of 27 |
| Insight and judgment | Good |

BP 126/74 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 52.1 kg; BMI 19.6 kg/m². All vital signs are synthetic.

## Data reviewed

The intake history and safety plan; PHQ-9 17 at intake and 16 today; GDS-15 10; MoCA 27; hemoglobin 12.6 g/dL, MCV 92 fL, white cells and platelets normal; sodium 139 mmol/L, potassium 4.1 mmol/L, creatinine 0.74 mg/dL, eGFR 88, glucose 88 mg/dL, calcium 9.4 mg/dL, albumin 3.8 g/dL; TSH 2.1 mIU/L; vitamin B12 410 pg/mL; folate 9.8 ng/mL; today's vital signs and weight (52.1 kg). PHQ-9: 16. All results are synthetic.

## Assessment

1. **Major depressive disorder, single episode, moderate** (F32.1). A major depressive episode of moderate severity in the setting of bereavement. Grief is present and is expected to need its own work, but the pervasive low mood, loss of pleasure, weight loss, slowed thinking, and death wish meet criteria for major depression rather than grief alone. No bipolar or psychotic features; no evidence of a neurocognitive disorder; normal tests exclude common medical causes. Suicide risk is low to moderate: older age, living without a partner, bereavement, and a recent passive death wish, set against faith, duty, close household staff, no firearms, controlled access to medicines, and good engagement. **S**
2. **Chronic insomnia comorbid with depression** (G47.00). Sleep-maintenance insomnia driven largely by the depression; diphenhydramine was rightly stopped. **S**

## Recommendations

1. Sertraline 25 mg each morning for one week, then 50 mg; review every two to four weeks and increase to 75 mg, then 100 mg if needed, only if the PHQ-9 has not fallen by at least 50 percent after six to eight weeks at 50 mg.
2. Avoid paroxetine, tricyclic antidepressants, and other strongly anticholinergic drugs; mirtazapine is a reasonable second choice if appetite and sleep fail to improve on sertraline.
3. Check sodium two to four weeks after starting sertraline, and again with any confusion, nausea, or unsteadiness; check orthostatic blood pressure and gait after starting and after dose changes, because SSRIs raise fall risk.
4. Individual interpersonal psychotherapy weekly, focused on grief and on the breach with her friend, combined with the antidepressant; group therapy is not suitable given her need for privacy.
5. I agree with the risk assessment and safety plan: review suicidal thoughts at every visit with PHQ-9 item 9 and the C-SSRS Since Last Visit, keep the 988 Lifeline and clinic number on the plan, and keep her medicines with her maid.
6. Cognitive behavioral therapy for insomnia, with a sleep window and stimulus control; no benzodiazepines, Z-drugs, or sedating antihistamines.
7. PHQ-9 and GDS-15 at least monthly; aim for remission and continue sertraline for at least six to twelve months after remission before a slow taper.
8. Please refer back if there is no response by about twelve weeks, if suicidal thoughts return or become active, if psychotic features or cognitive decline appear, or if she stops eating.

## Strengths and supports

- Supports: a few women of her household who have served her for decades, her chaplain, and daily prayer; she walks in the gardens most days **S**

## Communication

Discussed with Dr. Ashcombe-Nwosu the same day; Ms. Tudor agrees with the plan and asked that this note be shared with no one outside her care team. **S**

## Follow-up

Primary care continues with Dr. Ashcombe-Nwosu, with monthly measurement-based review. Geriatric psychiatry will see her again if needed, as above. **S**

## Guideline basis

- APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society (Journal of the American Geriatrics Society)
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016), American College of Physicians (Annals of Internal Medicine)
